ITGAM and neoplasm: At 21 days after GL261 and CT2A tumor implantation (14 days after ZIKV treatment), continued increases in numbers of Ly6C+ monocytes (~2- and 6.8-fold, respectively) were observed but not in numbers of neutrophils, F4/80+ macrophages, or CD11b+ monocyte-derived DCs (Figure 2, C and D).